Kelly C. Goldsmith

Also affiliated with Children's Healthcare of Atlanta

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin”.

Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin

Communications Biology(2024)10.1038/s42003-024-06140-6

N/A

0.345DataRank · unranked

9 citations

Garrett W. Cooper, Benjamin P. Lee, Yongdong Su, Katie T. Skinner, Jenny Shim +33 more

Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance

The Medicine Forum(2021)10.1101/2021.03.01.433120

N/A

0DataRank · unranked

2 citations

David M. Booth, J. Škoda, Madison C. Pedrotty, Jennifer Vogel, Kangning Liu +13 more

A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior

Advanced Science(2022)10.1002/advs.202200244

N/A

0DataRank · unranked

60 citations

Jenny Shim, Martin L. Tomov, Rui Liu, Riya Mehta, Andrew Mingee +8 more

Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials

OncoImmunology(2022)10.1080/2162402x.2022.2057012

N/A

0DataRank · unranked

19 citations

Rebecca E. Burnham, Andrew Ho, Adeiye A. Pilgrim, Jenny Shim, Christopher B. Doering +3 more

Targeting TRIP13 in Wilms Tumor with Nuclear Export Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.23.481521

N/A

0DataRank · unranked

5 citations

Benjamin P. Lee, Garrett W. Cooper, Jenny Shim, Hunter C. Jonus, Won Jun Kim +31 more

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10041

N/A

0DataRank · unranked

0 citations

Yaël P. Mossé, Kimberly Kayser, Yueh‐Yun Chi, Marc Chioda, Holger Thurm +14 more

The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1

OncoImmunology(2023)10.1080/2162402x.2023.2240678

N/A

0DataRank · unranked

20 citations

Hunter C. Jonus, Andrew K.S. Ho, Anna C. Cole, Jenny Shim, Kelly C. Goldsmith +1 more

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101091

N/A

0DataRank · unranked

18 citations

Hunter C. Jonus, Arhanti Sadanand, Gianna M. Branella, Victor Maximov, Suttipong Suttapitugsakul +13 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Protocol for 3D bioprinting of a 3D in vitro model of neuroblastoma

STAR Protocols(2025)10.1016/j.xpro.2025.103725

N/A

0DataRank · unranked

5 citations

Sarah Rezapourdamanab, Linqi Jin, Melissa Cadena, Kaveeta Kaw, Vani Sridhar +9 more